Site-Specific Modification of Proteins via Trypsiligase.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 24 7 2019
pubmed: 25 7 2019
medline: 9 4 2020
Statut: ppublish

Résumé

Site-specific incorporation of artificial functionalities into protein targets is an important tool in both basic and applied research and can be a major challenge to protein chemists. Chemical labeling methods often targeting multiple positions within a protein and therefore suffer from lack of specificity. Enzymatic protein modification is an attractive alternative due to the inherent regioselectivity and stereoselectivity of enzymes. In this contribution we describe the application of the highly specific trypsin variant named trypsiligase for the site-specific modification of virtual any target protein. We present two general routes of modification resulting in either N- or C-terminal functionalized protein products. Both reaction regimes proceed under mild and bioorthogonal conditions in a short period of time which result in homogeneously modified proteins bearing the artificial functionality exclusively at the desired position. We detail protocols for the expression and purification of trypsiligase as well as the construction of peptide or acyl donor ester probes used as substrates for the biocatalyst. In addition, we provide instructions how to perform the ultimate bioconjugation reactions and finally render assistance for the qualitative and quantitative analysis of the reaction course and outcome.

Identifiants

pubmed: 31332750
doi: 10.1007/978-1-4939-9654-4_8
doi:

Substances chimiques

Peptides 0
Trypsin EC 3.4.21.4
Ligases EC 6.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-115

Auteurs

Sandra Liebscher (S)

Charles-Tanford-Protein Center, Institute of Biochemistry/Biotechnology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

Frank Bordusa (F)

Charles-Tanford-Protein Center, Institute of Biochemistry/Biotechnology, Martin-Luther-University Halle-Wittenberg, Halle, Germany. frank.bordusa@biochemtech.uni-halle.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH